Search Page

1

Cite

Share

In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.

Ciavarella S, Grisendi G, Dominici M, Tucci M, Brunetti O, Dammacco F, Silvestris F. Ciavarella S, et al. Br J Haematol. 2012 Jun;157(5):586-98. doi: 10.1111/j.1365-2141.2012.09082.x. Epub 2012 Mar 16. Br J Haematol. 2012. PMID: 22420897

Cite

Share

2

Cite

Share

[Mesenchymal stem cells and bone regeneration].

Ciavarella S, De Matteo M, Cafforio P, Dammacco F, Silvestris F. Ciavarella S, et al. Recenti Prog Med. 2008 Feb;99(2):75-82. Recenti Prog Med. 2008. PMID: 18459681 Italian.

Cite

Share

3

Cite

Share

Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts.

Ciavarella S, Dammacco F, De Matteo M, Loverro G, Silvestris F. Ciavarella S, et al. Stem Cells Dev. 2009 Oct;18(8):1211-20. doi: 10.1089/scd.2008.0340. Stem Cells Dev. 2009. PMID: 19125623

Cite

Share

4

Cite

Share

Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both?

Silvestris F, Ciavarella S, De Matteo M, Tucci M, Dammacco F. Silvestris F, et al. Among authors: ciavarella s. Oncologist. 2009 Mar;14(3):264-75. doi: 10.1634/theoncologist.2008-0087. Epub 2009 Mar 13. Oncologist. 2009. PMID: 19286760 Review.

Cite

Share

5

Cite

Share

Targeted therapies in cancer.

Ciavarella S, Milano A, Dammacco F, Silvestris F. Ciavarella S, et al. BioDrugs. 2010 Apr 1;24(2):77-88. doi: 10.2165/11530830-000000000-00000. BioDrugs. 2010. PMID: 20199123 Review.

Cite

Share

6

Cite

Share

Mesenchymal stem cells: a new promise in anticancer therapy.

Ciavarella S, Dominici M, Dammacco F, Silvestris F. Ciavarella S, et al. Stem Cells Dev. 2011 Jan;20(1):1-10. doi: 10.1089/scd.2010.0223. Epub 2010 Sep 14. Stem Cells Dev. 2011. PMID: 20670160 Review.

Cite

Share

7

Cite

Share

Cell fusion and hyperactive osteoclastogenesis in multiple myeloma.

Silvestris F, Ciavarella S, Strippoli S, Dammacco F. Silvestris F, et al. Among authors: ciavarella s. Adv Exp Med Biol. 2011;714:113-28. doi: 10.1007/978-94-007-0782-5_5. Adv Exp Med Biol. 2011. PMID: 21506010 Review.

Cite

Share

8

Cite

Share

Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro.

Tucci M, Ciavarella S, Strippoli S, Brunetti O, Dammacco F, Silvestris F. Tucci M, et al. Among authors: ciavarella s. Exp Hematol. 2011 Jul;39(7):773-83.e1. doi: 10.1016/j.exphem.2011.04.006. Epub 2011 Apr 25. Exp Hematol. 2011. PMID: 21569821

Cite

Share

9

Cite

Share

[Cell-based strategies: novel perspectives for cancer therapy].

Simone V, Ciavarella S, D'Oronzo S, Silvestris F. Simone V, et al. Among authors: ciavarella s. Recenti Prog Med. 2012 Feb;103(2):49-55. doi: 10.1701/1045.11385. Recenti Prog Med. 2012. PMID: 22430747 Review. Italian.

Cite

Share

10

Cite

Share

Cell fusion in myeloma marrow microenvironment: role in tumor progression.

Cives M, Ciavarella S, Dammacco F, Silvestris F. Cives M, et al. Among authors: ciavarella s. Crit Rev Oncog. 2013;18(1-2):75-95. doi: 10.1615/critrevoncog.v18.i1-2.50. Crit Rev Oncog. 2013. PMID: 23237553 Review.

Cite

Share